Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Dawnrays Pharmaceutical (Holdings) Limited 2348.HK
$1.39
+$0.06 (4.51%)
На 18:03, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
2008378621.00000000
-
week52high
1.47
-
week52low
0.98
-
Revenue
1277682000
-
P/E TTM
0
-
Beta
0.80687000
-
EPS
0.27000000
-
Last Dividend
0.09000000
-
Next Earnings Date
26 мар 2023 г. в 11:36
Описание компании
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Свежие комментарии
Свежие комментарии